The Impact of Geographic Atrophy on Daily Behaviors of Individuals
Research type
Research Study
Full title
Understanding Behavioral Milestones in the Daily Life of People with Geographic Atrophy
IRAS ID
198615
Contact name
Amanda Spangler
Contact email
Sponsor organisation
Genentech Inc., a Member of Roche Group
Clinicaltrials.gov Identifier
N/A, N/A
Duration of Study in the UK
0 years, 6 months, 1 days
Research summary
Genentech has sponsored this study to better understand the lives of patients with geographic atrophy. Geographic atrophy is an eye condition that leads to blindness, typically among the elderly. Currently, there is very little known about the experience of living with the condition and how it impacts the daily lives of patients. Genentech is in one of the final stages of developing a drug that helps slow down the progression of geographic atrophy, and would like to understand the experience of living with the condition from a patient’s perspective. Note that this study does not involve giving participant's medication of any kind.
This study takes place in four countries around the world; one of which is the United Kingdom. In each country, five patients aged 65 and older will be observed and interviewed in their homes by an experienced researcher (field investigator) about their lifestyles and how it might be impacted by geographic atrophy. In addition, the participants will be filmed with a video camera throughout the interview. All of this research data will eventually be analyzed by experienced data analysts to identify key findings and themes.
REC name
London - City & East Research Ethics Committee
REC reference
16/LO/0398
Date of REC Opinion
24 Mar 2016
REC opinion
Further Information Favourable Opinion